146 related articles for article (PubMed ID: 8210633)
1. Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials.
Harbott J; Ritterbach J; Ludwig WD; Bartram CR; Reiter A; Lampert F
Recent Results Cancer Res; 1993; 131():123-32. PubMed ID: 8210633
[No Abstract] [Full Text] [Related]
2. DNA aneuploidy in childhood acute lymphoblastic leukemia: relation to clinical determinants and prognosis within four consecutive BFM trials.
Hiddemann W; Harbott J; Ludwig WD; Ritter J; Nehmer A; Reiter A; Kolkmeyer A; Laing T; Riehm H
Recent Results Cancer Res; 1993; 131():113-21. PubMed ID: 8210632
[No Abstract] [Full Text] [Related]
3. Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86.
Ludwig WD; Harbott J; Bartram CR; Komischke B; Sperling C; Teichmann JV; Seibt-Jung H; Notter M; Odenwald E; Nehmer A
Recent Results Cancer Res; 1993; 131():269-82. PubMed ID: 8210646
[No Abstract] [Full Text] [Related]
4. [Treatment strategy for childhood and adolescent acute lymphoblastic leukemia in first remission].
Hori H
Rinsho Ketsueki; 2010 Jul; 51(7):454-9. PubMed ID: 20693762
[No Abstract] [Full Text] [Related]
5. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial.
Kowalczyk JR; Zawitkowska J; Lejman M; Drabko K; Samardakiewicz M; Matysiak M; Romiszewski M; Balwierz W; Ćwiklińska M; Kazanowska B; Owoc-Lempach J; Wachowiak J; Derwich K; Adamkiewicz-Drożyńska E; Niedźwiecki M; Trelińska J; Młynarski W; Wysocki M; Kołtan A; Szczepański T; Krawczuk-Rybak M; Kitszel A; Wieczorek M; Urasiński T; Ociepa T; Sobol-Milejska G; Mizia-Malarz A; Karolczyk G; Stary J
Am J Hematol; 2019 Nov; 94(11):E307-E310. PubMed ID: 31432528
[No Abstract] [Full Text] [Related]
8. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
9. Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia.
Piskunova IS; Obukhova TN; Parovichnikova EN; Kulikov SM; Troitskaya VV; Gavrilina OA; Savchenko VG
Ter Arkh; 2018 Aug; 90(7):30-37. PubMed ID: 30701920
[TBL] [Abstract][Full Text] [Related]
10. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
11. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis.
Foroni L; Harrison CJ; Hoffbrand AV; Potter MN
Br J Haematol; 1999 Apr; 105(1):7-24. PubMed ID: 10366253
[No Abstract] [Full Text] [Related]
12. Immunologic subclassification of acute lymphoblastic leukemia in childhood and prognosis (modified BFM protocol).
Zintl F; Häfer R
Haematol Blood Transfus; 1989; 32():109-12. PubMed ID: 2696675
[No Abstract] [Full Text] [Related]
13. High hyperdiploid acute lymphoblastic leukemia (ALL)-A 25-year population-based survey of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
Reismüller B; Steiner M; Pichler H; Dworzak M; Urban C; Meister B; Schmitt K; Pötschger U; König M; Mann G; Haas OA; Attarbaschi A;
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27804199
[TBL] [Abstract][Full Text] [Related]
14. Therapy of acute lymphoid leukemia in children.
Pinkel D
Leukemia; 1992; 6 Suppl 2():127-31. PubMed ID: 1578914
[TBL] [Abstract][Full Text] [Related]
15. ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center.
Kocak U; Gursel T; Kaya Z; Aral YZ; Albayrak M; Keskin EY; Belen B; Isık M; Oner N
Pediatr Hematol Oncol; 2012 Mar; 29(2):130-40. PubMed ID: 22376016
[TBL] [Abstract][Full Text] [Related]
16. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002.
Stary J; Zimmermann M; Campbell M; Castillo L; Dibar E; Donska S; Gonzalez A; Izraeli S; Janic D; Jazbec J; Konja J; Kaiserova E; Kowalczyk J; Kovacs G; Li CK; Magyarosy E; Popa A; Stark B; Jabali Y; Trka J; Hrusak O; Riehm H; Masera G; Schrappe M
J Clin Oncol; 2014 Jan; 32(3):174-84. PubMed ID: 24344215
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics in adult acute lymphocytic leukemia.
Wetzler M
Hematol Oncol Clin North Am; 2000 Dec; 14(6):1237-49. PubMed ID: 11147221
[TBL] [Abstract][Full Text] [Related]
18. No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back-bone therapy.
Felice MS; Rossi JG; Gallego MS; Alfaro EM; Zubizarreta PA; Fraquelli LE; Alonso CN; Guitter MR; Scopinaro MJ
Pediatr Blood Cancer; 2011 Jul; 57(1):47-55. PubMed ID: 21394895
[TBL] [Abstract][Full Text] [Related]
19. [Cytogenetic study of acute and chronic leukemias].
Conte G; Torrens M; Larraín C; Be C; Daher V; Youlton R
Rev Med Chil; 1989 Feb; 117(2):135-41. PubMed ID: 2487950
[TBL] [Abstract][Full Text] [Related]
20. [Results and suggestion from comparing between world excellent protocols of childhood acute lymphoblastic leukemia].
Fu RY; Liao QK; Jia CS
Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):515-9. PubMed ID: 14746678
[No Abstract] [Full Text] [Related]
[Next] [New Search]
